GE HealthCare (GEHC), a leading global healthcare solutions provider, has announced that Yihao Zhang, president and Chief Executive Officer (CEO), China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao’s departure.
Song joins GE HealthCare from Johnson & Johnson, where he served as global senior vice president and China chairman. He led the China Presidents’ Council to advance Johnson & Johnson’s journey of innovation in China across MedTech and Innovative Medicine businesses. He joined Johnson & Johnson in 2003 and held various global positions with increasing responsibilities.
Well respected in the China market, over the past decade, Song has served as vice chairman of the China Association of Medical Devices Industry, vice president of the China Association of Enterprises with Foreign Investment, and vice chairman, Shanghai Enterprises Directors Association. He has been recognised with multiple external honors for his accomplishments, impact on the healthcare industry and broader economic development.
He is going to be based in Shanghai, China. Zhang and Song are working closely over the next several months to get immersed in the business, which is strategically important to the company’s growth strategy, and enable a deliberate and effective transition period.
